How Extraction Method Changes the Chemistry of Cannabis Extracts

By Dr. Miller Published Updated
One marijuana leaf presented in a high-contrast sketch treatment

The same cannabis cultivar can produce substantially different extracts depending on how it is processed, according to a 2021 study published in Scientific Reports. The findings suggest that labels such as “full spectrum” do not tell the whole story: the extraction method can alter the relative abundance of cannabinoids, other plant compounds, and minerals in the finished product.

In the original study, researchers from Colorado State University and Charlotte’s Web analyzed extracts made from a single high-CBD cannabis cultivar. Using material from the same production lot, they compared ethanol extraction, isopropyl alcohol extraction, and supercritical carbon dioxide extraction. The carbon dioxide process produced two fractions, collected at different separator pressures.

The researchers used several analytical techniques to examine the extracts. Gas chromatography–mass spectrometry identified 41 compounds, targeted ultra-performance liquid chromatography–tandem mass spectrometry assessed 15 phytocannabinoids, and inductively coupled plasma mass spectrometry measured 24 elements. Five replicate samples were analyzed for each extraction method.

The chemical profiles varied significantly across the methods. Fourteen of the 15 measured phytocannabinoids differed significantly in abundance among the extracts. In general, the ethanol and isopropyl alcohol extracts contained higher levels of several cannabinoids, including CBD and delta-9 THC, than the supercritical CO2 fractions. CBDA was an important exception: it was most abundant in one of the CO2 fractions.

The researchers attributed some of this difference to when decarboxylation occurred. The alcohol extracts were decarboxylated after extraction, while the plant material used for the CO2 process was heated before extraction. Because acidic cannabinoids such as CBDA can be converted into neutral cannabinoids such as CBD by heat, the timing and conditions of that step may have influenced the results.

Extraction also affected compounds beyond the major cannabinoids. The study found differences in substances including fatty acids, polyols, carbohydrates, terpenoid-related compounds, and plant sterols. Ten of the 24 measured elements—including potassium, magnesium, manganese, sodium, sulfur, phosphorus, and molybdenum—also varied among the extracts. Cadmium, lead, and arsenic were not significantly affected by the extraction method and were not detected above the regulatory levels used for comparison in the study.

These results do not show that one extraction technique produces a more effective or safer therapeutic product. The study measured chemical composition, not clinical outcomes, and it examined one cultivar under specific processing conditions. The authors also noted that several compounds identified by non-targeted GC–MS analysis were assigned through database matching rather than confirmation with authentic standards.

Still, the work has practical implications for manufacturers, researchers, and consumers. Two products made from genetically similar or identical plant material may not have equivalent chemical profiles if they are extracted differently. A later comparison of ethanol, supercritical CO2, and hydrodistillation likewise found distinct cannabinoid and terpene profiles, reinforcing the importance of documenting processing conditions rather than relying only on the cultivar name.

For cannabis products intended for research or medical use, the findings support more detailed labeling and routine chemical testing. Reporting the extraction solvent or technology, decarboxylation conditions, and measured concentrations of relevant compounds could make multi-component extracts easier to compare and study. Chemical consistency is an essential first step before researchers can determine whether processing-related differences translate into meaningful differences in biological or therapeutic effects.

dr paul miller md

About the Author: Dr. Miller

Dr. Miller is committed to finding new and innovative ways to help his patients manage their symptoms and improve their overall quality of life. He has a particular interest in the therapeutic potential of medical cannabis and is passionate about educating both his colleagues and patients on its safe and effective use. He is also committed to continuing his education and staying up-to-date on the latest advances in neurology and cannabis research.